Melissa Accordino, MD, MS (@maccordino) 's Twitter Profile
Melissa Accordino, MD, MS

@maccordino

Breast Medical Oncologist and Health Outcomes Researcher @Columbia. Fantasy football/Bucs fan. Food lover. Mom of twin boys. Tweets/opinons are my own.

ID: 120858704

calendar_today07-03-2010 19:55:51

50 Tweet

450 Followers

1,1K Following

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Pts who pursued #ComplementaryMedicine for breast, prostate, colon, or lung cancer had a significantly worse overall survival, likely explained by delays in or refusal to pursue conventional #cancer therapies ja.ma/2LfxfzL #CAM

Melissa Accordino, MD, MS (@maccordino) 's Twitter Profile Photo

#Scanxiety can greatly affect our patients #qualityoflife. SWOG Cancer Research Network 1703 swog.org/clinical-trial… is open and will help determine if #tumormarker directed monitoring can reduce scanxiety and improve #qol, and #costsofcare in #bcsm without affecting survival.

Melissa Accordino, MD, MS (@maccordino) 's Twitter Profile Photo

#HeartDisease is also the #1 cause of death among #breastcancer #survivors. After diagnosis It is important to encourage adherence to both #bcsm medications and to #cardiovascular medications onclive.com/conference-cov… Dawn Hershman Nisha Jhalani, MD Herbert Irving Comprehensive Cancer Center

Melissa Accordino, MD, MS (@maccordino) 's Twitter Profile Photo

Congratulations Dawn Hershman!! Thanks for all you do - truly an inspiration to all of us!! We all hope to be like you when we “grow up” #mentor #GirlPower #WomenInMedicine #WomeninScience #PatientCare #clinicaltrials #qualitycare #bcsm #caredelivery #notenoughcharacters

Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (@tomleblancmd) 's Twitter Profile Photo

More useable electronic medical records systems are associated with improved physician efficiency and performance. Next generation #EMR platforms can help clinicians work smarter, instead of just harder. These improvements are long overdue: jamanetwork.com/journals/jaman… #burnout

SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

In patients with metastatic, HR+, HER2- #breastcancer with initially elevated levels of serum tumor markers, can levels be used to monitor treatment response? SWOG Cancer Research Network S1703 is for patients about to start treatment or within their first 60 days SWOG.org/clinical-trial… Komal Jhaveri

In patients with metastatic, HR+, HER2- #breastcancer with initially elevated levels of serum tumor markers, can levels be used to monitor treatment response? <a href="/SWOG/">SWOG Cancer Research Network</a> S1703 is for patients about to start treatment or within their first 60 days SWOG.org/clinical-trial… <a href="/jhaveri_komal/">Komal Jhaveri</a>